ATM and esophageal squamous cell carcinoma: In the study, data from colonial survival assays showed that ATM inhibitor KU-55933 strongly enhanced the cell growth inhibition of EC1/shRAP80 #1 cells(Fig. 4e), uncovering a possible combination therapy of RAP80 inhibitors and ATM inhibitors for ESCC patients.